MIAKER Developments

Logo MIAKER Developments

Contact information

Logo MIAKER Developments
Emilio González, COO/CSO // Ioana Croitoru, Project Manager, Regulatory and Scientific Affairs in MIAKER CRO
Paseo Miramón 170, Edificio Tandem
659107731 // 664506415
Areas of activities
  • Areas of activity
    • Medical devices
    • Drug development
    • Drug discovery
  • Therapeutic areas
    • Central nervous system
  • D. Services
    • Professional services
      • Consultancy

R&D for the Development of Therapeutics for the treatment of Neurodegenerative and Neuromuscular diseases, and services in the area of Drug Discovery in these disorders.

Design and Development of Clinical Trials.

Products and services

In vitro tests for drug screening and studies of the mechanism of action (MOA) in early stages of preclinical development for the treatment of Neurodegenerative and Neuromuscular diseases.

MIAKER Bioassays provides in vitro cell assays and a Platform, PLATFLY, for small molecule low-medium throughput in vivo screening in fruit flies (Drosophila melanogaster) for Neurodegenerative and Neuromuscular diseases.

MIAKER CRO is dedicated to the Design and Development of clinical trials of Pharmaceutical Drugs and Nutraceuticals, as well as the clinical development of proofs of concept clinical studies and clinical trials of medical devices.

Areas of interest for future collaborations

Neurodegenerative and neuromuscular diseases such as: Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, Alzheimer's Disease, Frontotemporal Dementia and Myotonic Dystrophy 1. 

Clinical trials development.